Blood Advances
ISSN: 2473-9529
eISSN: 2476-9537
Publisher: American Society of Hematology
Publications (33)
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023)
Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al.
Journal article
The utility of biomarkers in acute GVHD prognostication (2023)
Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, et al.
Journal article
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD (2023)
Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, et al.
Journal article
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia (2023)
Heidenreich F, Falk B, Baldauf H, Massalski C, Schäfer G, Rücker-Braun E, Altmann H, et al.
Journal article
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany (2023)
Bader P, Rossig C, Hutter M, Ayuk FA, Baldus CD, Bücklein VL, Bonig H, et al.
Journal article
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023)
Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al.
Journal article, Letter
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use (2023)
Weber D, Weber M, Meedt E, Ghimire S, Wolff D, Edinger M, Poeck H, et al.
Journal article
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL (2023)
Blumenberg V, Busch G, Baumann S, Jitschin R, Iacoboni G, Gallur L, Iraola-Truchuelo J, et al.
Journal article
Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans (2022)
Brandl A, Solimando AG, Mokhtari Z, Tabares P, Medler J, Manz H, Da Via MC, et al.
Journal article
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022)
Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al.
Journal article